JOJulia Vladimirovna Oslopova

Julia Vladimirovna Oslopova

*This is an algorithmically generated author record based on publicly available information.

Julia Vladimirovna Oslopova has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Nikolay S. Korotkov is a lonely and extraordinary star in the firmament of the great names of world science (on the 120th anniversary of the creation of the sound detection method blood pressure by Russian surgeon Nikolay S. Korotkov)

    by V. N. Oslopov, A. A. Terekhova, I. V. Frauch, A. M. Kuznetsova, Yu. V. Oslopova, E. M. Karimullina, D. V. Oslopova, E. V. Khazova

    It has been 120 years since the Russian surgeon Nikolay S. Korotkov, during the war (the war with Japan), in the field conditions, created a sound method for determining blood pressure in humans. The method later brought worldwide fame to its creator, through him to the entire Russian science, and still remains the "golden" standard for non-invasive measurement of blood pressure in humans. The process of creating the method itself (from the point of view of some scientists, being ambiguous: random — not random?) It is undoubtedly of great interest as an example of a fruitful combination of intelligence, hard work, perseverance, luck and timely help from a senior mentor. Korotkov's method began to be used abroad after the article by J. Erlander was born in the USA (in 1916) and then he conquered the whole world, but In Russia, for unknown reasons, the name of Nikolay S. Korotkov was hushed up for many years. After being informed about the creation of the method, i.e. after 1905, N. S. Korotkov never used his method again, he did not create a new field of medicine based on his method, did not establish scientific schools in either surgery or therapy, did not obtain patents, and did not have any students, monographs, or articles, either In Russia or abroad. He died at the age of 46 from a massive pulmonary hemorrhage, having suffered from bilateral pulmonary tuberculosis. Therefore, Nikolay S. Korotkov's "star" is "lonely" and "extraordinary". The "extraordinary" nature of Nikolay S. Korotkov's phenomenon lies in the social paradox that if there had been no war, the method itself would not have been created. The article suggests understanding Nikolay S. Korotkov's phenomenon by delving into the events of 120 years ago. Korotkov's "path", which is unusual in many ways, can serve as an example for scientific endeavors even today.

  • Open Access

    The pinnacle of S. S. Zimnitsky scientific work — nephrology research

    by V. N. Оslopov, E. V. Khazova, N. R. Khasanov, Yu. V. Oslopova, Yu. S. Mishanina, D. V. Oslopova

    The pinnacle of S. S. Zimnitsky scientific heritage is the Zimnitsky, which makes it possible to assess the renal function without invasive procedures and burdening the patient. Proposed a hundred years ago, the Zimnitsky test shows its effectiveness at the present time. S. S. Zimnitsky proposed an original classification of hydronephrosis, described a special form of nephritis and rejected the filtration theory of urine formation, promoting the secretory one. In his purely scientific nephrological articles, S. S. Zimnitsky acts as a sincere and ardent patriot of his great homeland.


  • Open Access

    S. S. Zimnitsky — the creator of the functional direction in internal medicine. The outset — research in gastroenterology

    by V. N. Оslopov, E. V. Khazova, N. R. Khasanov, Yu. V. Oslopova, Yu. S. Mishanina, D. V. Oslopova

    Semen Semenovich Zimnitsky is an outstanding Russian internist of the early XX century. He created a functional direction and made a significant contribution to internal medicine, infectiology, immunology and microbiology, but his studies of gastroenterology are fundamental. The Zimnitsky’s works on hepatology, pancreatic diseases, and balneology are interesting. S. S. Zimnitsky discovered 5 types of gastric secretion, which turned out to be reversible, and proposed a repeated breakfast. The pinnacle of his work is Zimnitsky’s test, which makes it possible to determine the renal function without resorting to any invasive procedures and in no way burdening the patient. The onset of test creation was laid by S. S. Zimnitsky in his doctoral dissertation devoted to gastroenterology.


  • Anemia of chronic diseases: a verdict or a protective reaction of the body?

    by Azaliya D. Valitova, Zulfinaz M. Kadyrova, Vladimir N. Oslopov, Yulia V. Oslopova, Elena V. Khazova

    Anemia of chronic disease occurs in patients with infectious, autoimmune, kidney diseases, neoplasia, inflammatory bowel disease, obesity, diabetes mellitus, congestive heart failure, and chronic lung disease. This variant of anemia is characterized primarily by impaired iron homeostasis, the suppressive effect of pro-inflammatory cytokines on erythropoiesis, and changes in the erythrocyte membrane that worsen their survival. Anemia of chronic disease is micro- or normocytic anemia with low levels of reticulocytes. In anemia of chronic disease, serum iron and transferrin levels are usually reduced or normal, and serum ferritin levels are within reference values or elevated. The article provides a review of studies on epidemiology, including age aspects, provides information on the etiology and prognosis in patients with anemia of chronic diseases. The issues of the history of anemia of chronic diseases and its place in the structure of all anemias are also covered. Anemia of inflammation is recognized as a widespread pathology; it occupies 40% in the structure of all anemias. It is important to note that anemia of chronic diseases, while accompanying a number of dangerous diseases, actually serves as a natural defense mechanism. This is due to the occurrence of iron starvation for microorganisms, since inflammatory reactions increase the synthesis of iron proteins, which quickly extract extracellular and unbound iron. This mechanism allows a person to destroy the infection in time with the help of innate immunity. The article reveals the pathogenetic aspects of anemia of inflammation development and data on the role of iron in the functioning of macro- and microorganisms. Particular attention is paid to the differential diagnosis of anemia of chronic diseases and iron deficiency anemia, key diagnostic hematological markers of anemia, iron metabolism, inflammation and erythropoiesis are given. The pros and cons of therapy options, as well as possible new pathogenetic methods for the treatment of anemia of chronic diseases, are described.


  • Open Access

    Semen Semenovich Zimnitsky Scientific School: Pulmonology and Cardiology

    by V. N. Oslopov, N. R. Khasanov, Yu. V. Oslopova, E. V. Khazova, Yu. S. Mishanina, D. V. Oslopova

    Semen Semenovich Zimnitsky was a great Russian internist, a participant in the Russo-Japanese War (1904-1905). He proved that soldiers wounded by pointed bullets are seriously injured they need annual leave. S. S. Zimnitsky can be considered one of the founders of battlefield internal medicine in Russia. In the work "Diseases of the pulmonary parenchyma and pleura", he described croupous pneumonia and "abdominal syndrome" with dry pleurisy. He also concludes that pulmonary tuberculosis is not a local disease but involves the whole organism, the state of defensive mechanisms of which determines both the disease performance and the results of immunological and biological tests.The direction in internal medicine, created by S. S. Zimnitsky, was clearly reflected in following cardiology issues: heart failure, coronary artery disease, hypertension, bacterial endocarditis.


  • Open Access

    Semen Semenovich Zimnitsky’s contribution to the description of the clinic of infectious diseases, microbiology and immunology

    by V. N. Oslopov, E. V. Khazova, S. V. Khaliullina, N. R. Khasanov, Yu. V. Oslopova, Yu. S. Mishanina, D. V. Oslopova

    The early period of S. S. Zimnitsky scientific activity is characterized by a passion for microbiology, immunology and infectious diseases. Of great importance was the three-year work abroad with I. I. Mechnikov and R. Virkhov. S. S. Zimnitsky gained worldwide fame for his discovery of Manchurian typhus. S. S. Zimnitsky investigated blood complements, proved the presence of "group immuniziny", treated croupous pneumonia with monovalent serum. An analysis of S. S. Zimnitsky works in the field of infectious diseases, microbiology and immunology, several biochemical studies indicate the great contribution of the scientist to the development of Russian biological science.


  • Open Access

    Clinical and pedagogical school of Semen Semenovich Zimnitsky

    by V. N. Oslopov, N. R. Khasanov, Yu. V. Oslopova, E. V. Khazova, Yu. S. Mishanina, D. V. Oslopova

    The clinical and pedagogical school of Semyon Semyonovich Zimnitsky is described in close connection with the evolution of his academic status, changes in clinical bases and the social structure of society at the beginning of the 20th century. S. S. Zimnitsky took part in the creation of the Clinical Institute, opened the department of infectious diseases, founded the department of propaedeutics of internal diseases at Kazan State University. The outstanding talent of the lecturer and deep knowledge of clinical material won the love of affection and junior doctors. S. S. Zimnitsky creates methods for teaching therapy at the patient bedside in practical classes and in a lecture course, has an active professional position and is fighting with unreconstructed university professors.


  • High-density lipoprotein cholesterol — friend or enemy?

    by Adela F Murzakhanova, Vladimir N Oslopov, Konstantin S Sergienko, Elena V Khazova, Julia V Oslopova, Мурзаханова Аделя Фанисовна, Хазова Елена Владимировна

    The article provides a review of the literature on the effect of excess and deficiency of high-density lipoprotein cholesterol on the prevention and treatment of cardiovascular pathology. Information about high-density lipoproteins structure, function, antiatherogenic role and the prospect of using various high-density lipoproteins subclasses in the pharmacotherapy of dyslipidemic conditions are also described. It is proven that a lowered level of such cholesterol is a predictor of cardiovascular disease. At the same time, many observations confirm the correlation between elevated high-density lipoprotein levels and mortality from myocardial infarction and other acute cardiovascular conditions. In large studies, the use of cholesterol ester transfer protein inhibitors and other drugs increased the level of high-density lipoprotein, but the unreduced risk of cardiovascular disease confirms the lack of positive results from the use as a therapeutic target. In addition, it was found that the composition of high-density lipoprotein cholesterol protein differs in healthy and diseased people: it becomes dysfunctional, losing its antioxidant and anti-inflammatory properties in diseased individuals. The atheroprotective activity of properly functioning high-density lipoprotein cholesterol is often impaired in clinical situations associated with oxidative stress. In these cases, high-density lipoproteins can have some changes, and even if the quantity is within the normal range, the quality is no longer the same. Thus, it is necessary to identify a better therapeutic target than high-density lipoprotein cholesterol levels, as there is currently insufficient clinical trial data to recommend targeted high-density lipoprotein therapy.

  • The Effect of Ecdystene on the Activity of Matrix Metalloproteinases in Experimental Alloxan Diabetes in Rats

    by Djakhangir Khusanovich Tursunov, Rixsi Abdukadirovna Sabirova, Munojat Usmanovna Kulmanova, Khurshida Sabirovna Yusupkhodzhaeva, Maxim Sergeevich Kaligin, Alsu Ildusovna Abdrakhmanova, Julia Vladimirovna Oslopova, Railya Valievna Garipova


  • Open Access

    Fecal microbiota transplantation: donor selection criteria, storage and preparation of biomaterials (review of current recommendations)

    by A A Iakupova, S R Abdulkhakov, A G Safin, I M Alieva, J V Oslopova, R A Abdulkhakov

    Fecal microbiota transplantation is a treatment method based on the introduction of donated fecal material to the recipient in order to restore the damaged composition of the intestinal microbiota. This review summarizes existing data on indications for fecal microbiota transplantation, recommendations for donor selection, processing and storage of donor biomaterial.